Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "BamHI" patented technology

BamH I (from Bacillus amyloliquefaciens) is a type II restriction endonuclease, having the capacity for recognizing short sequences (6 b.p.) of DNA and specifically cleaving them at a target site. This exhibit focuses on the structure-function relations of BamH I as described by Newman, et al. (1995). BamH I binds at the recognition sequence 5'-GGATCC-3', and cleaves these sequences just after the 5'-guanine on each strand. This cleavage results in sticky ends which are 4 b.p. long. In its unbound form, BamH I displays a central b sheet, which resides in between α-helices. BamH I is an extraordinarily unique molecule in that it undergoes a series of unconventional conformational changes upon DNA recognition. This allows the DNA to maintain its normal B-DNA conformation without distorting to facilitate enzyme binding. BamH I is a symmetric dimer. DNA is bound in a large cleft that is formed between dimers; the enzyme binds in a "crossover" manner. Each BamH I subunit makes the majority of its backbone contacts with the phosphates of a DNA half site but base pair contacts are made between each BamH I subunit and nitrogenous bases in the major groove of the opposite DNA half site. The protein binds the bases through either direct hydrogen bonds or water-mediated H-bonds between the protein and every H-bond donor/acceptor group in the major groove. Major groove contacts are formed by atoms residing on the amino-terminus of a parallel 4 helix bundle. This bundle marks the BamH I dimer interface, and it is thought that the dipole moments of the NH2-terminal atoms on this bundle may contribute to electrostatic stabilization.

Construction of chemiluminescent reporter plasmid and application of chemiluminescent reporter plasmid in detecting transcription level of target gene of acetobacter pasteurianus

The invention belongs to the field of molecular biology and genetic engineering, and discloses a chemiluminescent reporter plasmid pBBR402 and application thereof in detection of the transcription level of a target gene of acetobacter pasteurianus. The plasmid comprises a replication element (oriV and rep) from a pBBR1MCS-2 plasmid, a kanamycin resistance gene from a pMS402 plasmid, a promoter insertion site (BamHI / AvaI / XhoI), a luxCDABE reporter gene cluster and a T1 transcription terminator, and the kanamycin resistance gene, the promoter insertion site (BamHI / AvaI / XhoI), the luxCDABE reporter gene cluster and the T1 transcription terminator are obtained from the pBBR1MCS-2 plasmid. The plasmid can be inserted into a to-be-detected gene promoter of acetobacter pasteurianus to drive luxCDABE expression. During application, the recombinant plasmid is transferred into acetobacter pasteurianus, the OD value and the LUM value of the living bacteria liquid are directly detected, and the transcription level is quantified by the LUM / OD value. The method is easy to operate, high in sensitivity and suitable for gene regulation and control research of acetobacter pasteurianus.
Owner:CHINA UNIV OF PETROLEUM (EAST CHINA)

Application of transgenic zebrafish in preparation of animal model capable of visually monitoring mast cells

The invention discloses application of transgenic zebrafish in preparation of an animal model capable of visually monitoring mast cells. The transgenic zebrafish is prepared by the following method: respectively carrying out XhoI and BamHI double enzyme digestion on a cpa5 gene promoter sequence (SEQ ID NO: 1) and plasmids with fluorescent protein genes and Tol2 transposon recognition sites, and then connecting to obtain recombinant plasmids; and then introducing the recombinant plasmid and Tol2 transposase mRNA into a zebra fish embryo in a microinjection mode in a 1-cell period of zebra fish embryo development, and culturing at constant temperature to obtain the transgenic zebra fish. The cpa5 promoter is constructed to drive an expression framework of the fluorescent protein, so that the mast cells naturally emit fluorescence in the zebra fish body, and an effective animal model is provided for mechanism research and drug screening of mast cell related diseases.
Owner:SOUTH CHINA UNIV OF TECH

DNA structure for saccharomyces cerevisiae single-cell barcode labeling and chromatin state conjoint analysis and application thereof

The invention discloses a DNA structure for saccharomyces cerevisiae single-cell barcode labeling and chromatin state conjoint analysis and application thereof, and belongs to the technical field of molecular biology and single-cell multi-omics analysis. From the 5'end to the 3 'end, a fluorescent protein gene, a Tn5ME structure, a reverse transcription primer binding region, a CYC1 terminator fragment and a linearized shuttle plasmid skeleton are subjected to homologous recombination, and a pCM carrier is obtained; after NdeI / BamHI enzyme digestion, oligonucleotides with random sequences, which are subjected to annealing, amplification, Klenow filling-in and enzyme digestion, are connected, and transformation extraction is carried out, so that the DNA structure for saccharomyces cerevisiae single-cell barcode labeling and chromatin state combined analysis is obtained. On the basis of the constructed DNA structure, ATAC-seq and a bar code reverse transcription method are combined, important data related to the transcription state and chromatin state of a single cell can be obtained at the same time through bar code information, single cell pedigree tracking of the saccharomyces cerevisiae is achieved, and research on single cell epigenomics of the saccharomyces cerevisiae and other microorganisms is promoted.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Plant circRNA expression framework and applications thereof

The application discloses a plant circRNA expression framework and application thereof, and belongs to the technical field of molecular biology. The plant circRNA expression framework is constructed by placing a Vv-circSIZ1 upstream flanking intron sequence and a Vv-circSIZ1 downstream flanking intron sequence on both sides of a low-expression circRNA. Further, the plant circRNA expression framework is inserted into a vector skeleton between BamHI and PstI of a circRNA-OE carrier plasmid constructed in the early stage by a homologous recombination method, so as to construct a plant circRNA overexpression carrier. The plant circRNA expression framework and the plant circRNA overexpression carrier can greatly improve the circularization efficiency of the low-expression circRNA, reduce the difficulty of constructing a carrier containing a long intron circRNA, and provide an effective method for studying the function of the plant circRNA.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Baculovirus expression vector and construction method and application thereof

The invention discloses a baculovirus expression vector as well as a construction method and application thereof. The vector takes pFastBacDual as a skeleton, 2-9 repetitive BS sequence modification promoters are connected in series to the downstream of a polh promoter, an extremely advanced transcription factor VLF-1 gene is introduced, and the two components synergistically enhance the transcriptional activity. According to the invention, three types of recombinant vectors pBSX-eGFP, pBSX-eV and pBSX-GV are constructed, and the optimal combination is determined as overexpression of two repeated BS sequences and VLF-1, so that the expression quantity of the target protein can be increased. The vector construction process is standardized, enzyme cutting sites such as BamHI and EcoRI are reserved, and high-expression protein can be obtained after Sf9 cells are transfected and cultured for 4-5 days. The recombinant protein expression efficiency of a baculovirus expression system is improved, the advantages of correct folding and post-translational modification of the recombinant protein are reserved, and the method is suitable for large-scale industrial recombinant protein production scenes such as biopharmacy and vaccine research and development and has important application value.
Owner:YANGZHOU UNIV

H5N1 nucleoprotein prokaryotic expression vector and method for inducing expression of nucleoprotein by using the same

The present application relates to a kind of H5N1 nucleoprotein prokaryotic expression vector and the method for its nucleoprotein induced expression, belong to the field of bioengineering, the H5N1 nucleoprotein base sequence optimized by in vitro synthesis in the present application, by enzyme cutting site BamHI and XhoI, the H5N1 nucleoprotein optimized base sequence is constructed into PGEX-6P-1 plasmid and obtains H5N1 nucleoprotein prokaryotic expression vector;After being transformed into BL21 competent bacteria by H5N1 nucleoprotein prokaryotic expression vector, inoculate in LB solid culture medium with ampicillin resistance and culture, pick single bacterial clone and inoculate into LB liquid culture medium with ampicillin resistance and culture, finally, IPTG culture induction is obtained, and the nucleoprotein fusion protein of induced expression is obtained, and the nucleoprotein of H5N1 is well expressed, and the fusion protein is obtained, which provides the basis for studying more significant, more durable immunity and effective H5N1 vaccine.
Owner:WEIRUI BIOTECHNOLOGY (KUNMING) CO LTD +1

H5N1 nucleoprotein prokaryotic expression vector and method for carrying out nucleoprotein induced expression by using H5N1 nucleoprotein prokaryotic expression vector

The invention relates to an H5N1 nucleoprotein prokaryotic expression vector and a nucleoprotein induced expression method thereof, and belongs to the field of bioengineering.The H5N1 nucleoprotein prokaryotic expression vector is obtained by synthesizing an optimized H5N1 nucleoprotein base sequence in vitro and constructing the optimized H5N1 nucleoprotein base sequence into a PGEX-6P-1 plasmid through enzyme cutting sites BamHI and XhoI; the method comprises the following steps: transforming an H5N1 nucleoprotein prokaryotic expression vector into BL21 competent bacteria, inoculating the BL21 competent bacteria into an ampicillin-resistant LB solid culture medium for culture, selecting single bacteria, cloning and inoculating the single bacteria into an ampicillin-resistant LB liquid culture medium for culture, and finally adding IPTG (isopropyl-beta-d-thiogalactoside) for culture and induction to obtain induced expression nucleoprotein fusion protein. The acquisition of the fusion protein provides a basis for researching H5N1 vaccines with more remarkable and more lasting immunity and effectiveness.
Owner:WEIRUI BIOTECHNOLOGY (KUNMING) CO LTD +1